All eyes are on UBS Group AG as it prepares to release its quarterly figures this Wednesday, following a steep 22% decline in its share price over the past month. The significant drop has placed immense pressure on the bank’s management to deliver a strong performance and reverse the negative trend. Market participants are keenly awaiting the report to gauge the health of the financial giant.
Lowered Expectations Set the Stage
Ahead of the publication, consensus among market experts points to significantly tempered expectations. For the fourth quarter of 2025, analysts now anticipate earnings per share (EPS) of just $0.25, a marked downward revision from earlier, more optimistic forecasts. Quarterly revenue is projected to be approximately $11.62 billion.
These figures will serve as a crucial benchmark for assessing the bank’s progress in integrating Credit Suisse. Investors are focused on understanding how efficiently the merger has been finalized over the past year and evaluating the resilience of the core business operations within the current interest rate environment. The subdued expectations confront a technically weakened stock, which currently trades at 37.56 Swiss francs—substantially below its 52-week high of 48.11 francs.
Should investors sell immediately? Or is it worth buying UBS?
Strategic Moves Amid Financial Scrutiny
Beyond the immediate financial metrics, UBS continues to advance its strategic priorities in wealth management. In January 2026, Nicholas Hinnen assumed the role of Head of Premium Advisory Specialists APAC Switzerland. He will lead a team dedicated to providing complex cross-asset advisory services for ultra-high-net-worth (UHNW) clients in the Asia-Pacific region. This appointment underscores the bank’s commitment to strengthening its market leadership in asset management through specialized, high-value services.
Product development remains active. Recent SEC filings from February 2nd reveal that UBS is issuing new structured financial products, including “Trigger Callable Contingent Yield Notes” linked to major indices. This activity signals ongoing engagement in the derivative investment solutions space.
Capital Return in the Spotlight
The report released on Wednesday, February 4, 2026, is expected to set the tone for the coming weeks. While meeting the $0.25 EPS estimate is important, the primary focus for many will be the forward-looking guidance for 2026. Concrete statements from management regarding dividend policy and the planned scale of the share buyback program will be pivotal in rebuilding investor confidence after the recent share price losses.
Ad
UBS Stock: Buy or Sell?! New UBS Analysis from February 3 delivers the answer:
The latest UBS figures speak for themselves: Urgent action needed for UBS investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 3.
UBS: Buy or sell? Read more here...
